591 related articles for article (PubMed ID: 33347668)
1. Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti-inflammatory activity, and the gut microbiota-liver-brain axis.
Daily JW; Kang S; Park S
Biofactors; 2021 Mar; 47(2):218-231. PubMed ID: 33347668
[TBL] [Abstract][Full Text] [Related]
2. Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.
Bosch ME; Dodiya HB; Michalkiewicz J; Lee C; Shaik SM; Weigle IQ; Zhang C; Osborn J; Nambiar A; Patel P; Parhizkar S; Zhang X; Laury ML; Mondal P; Gomm A; Schipma MJ; Mallah D; Butovsky O; Chang EB; Tanzi RE; Gilbert JA; Holtzman DM; Sisodia SS
Mol Neurodegener; 2024 Feb; 19(1):18. PubMed ID: 38365827
[TBL] [Abstract][Full Text] [Related]
3. The combination of luteolin and l-theanine improved Alzheimer disease-like symptoms by potentiating hippocampal insulin signaling and decreasing neuroinflammation and norepinephrine degradation in amyloid-β-infused rats.
Park S; Kim DS; Kang S; Kim HJ
Nutr Res; 2018 Dec; 60():116-131. PubMed ID: 30527255
[TBL] [Abstract][Full Text] [Related]
4. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
[TBL] [Abstract][Full Text] [Related]
5. Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease.
Kwon Y
Exp Gerontol; 2017 Sep; 95():39-43. PubMed ID: 28528007
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the Potential Neuroprotective Effects of Luteolin against Aβ
Ahmad S; Jo MH; Ikram M; Khan A; Kim MO
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502488
[TBL] [Abstract][Full Text] [Related]
7. A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.
Sun M; Ma K; Wen J; Wang G; Zhang C; Li Q; Bao X; Wang H
J Alzheimers Dis; 2020; 73(3):849-865. PubMed ID: 31884474
[TBL] [Abstract][Full Text] [Related]
8.
Kim DS; Ko BS; Ryuk JA; Park S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326255
[TBL] [Abstract][Full Text] [Related]
9. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.
de la Monte SM
Drugs; 2012 Jan; 72(1):49-66. PubMed ID: 22191795
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effect of luteolin is related to the changes in the gut microbiota and contributes to preventing the progression from simple steatosis to nonalcoholic steatohepatitis.
Sun WL; Yang JW; Dou HY; Li GQ; Li XY; Shen L; Ji HF
Bioorg Chem; 2021 Jul; 112():104966. PubMed ID: 33991837
[TBL] [Abstract][Full Text] [Related]
11. Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice.
Zhang Z; Tan X; Sun X; Wei J; Li QX; Wu Z
J Nutr; 2022 Jan; 152(1):140-152. PubMed ID: 34636875
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic noise exposure on the microbiome-gut-brain axis in senescence-accelerated prone mice: implications for Alzheimer's disease.
Cui B; Su D; Li W; She X; Zhang M; Wang R; Zhai Q
J Neuroinflammation; 2018 Jun; 15(1):190. PubMed ID: 29933742
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
Nagu P; Parashar A; Behl T; Mehta V
J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
[TBL] [Abstract][Full Text] [Related]
14. Effect of Clostridium butyricum against Microglia-Mediated Neuroinflammation in Alzheimer's Disease via Regulating Gut Microbiota and Metabolites Butyrate.
Sun J; Xu J; Yang B; Chen K; Kong Y; Fang N; Gong T; Wang F; Ling Z; Liu J
Mol Nutr Food Res; 2020 Jan; 64(2):e1900636. PubMed ID: 31835282
[TBL] [Abstract][Full Text] [Related]
15. Berberine alleviates Alzheimer's disease by regulating the gut microenvironment, restoring the gut barrier and brain-gut axis balance.
Sun C; Dong S; Chen W; Li J; Luo E; Ji J
Phytomedicine; 2024 Jul; 129():155624. PubMed ID: 38678955
[TBL] [Abstract][Full Text] [Related]
16. Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer's Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota.
Li C; Wang N; Zheng G; Yang L
ACS Appl Mater Interfaces; 2021 Oct; 13(39):46406-46420. PubMed ID: 34569225
[TBL] [Abstract][Full Text] [Related]
17. Pseudostellaria heterophylla polysaccharide mitigates Alzheimer's-like pathology via regulating the microbiota-gut-brain axis in 5 × FAD mice.
He C; Jiang J; Liu J; Zhou L; Ge Y; Yang Z
Int J Biol Macromol; 2024 Jun; 270(Pt 2):132372. PubMed ID: 38750854
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
[TBL] [Abstract][Full Text] [Related]
19. Mannan oligosaccharide attenuates cognitive and behavioral disorders in the 5xFAD Alzheimer's disease mouse model via regulating the gut microbiota-brain axis.
Liu Q; Xi Y; Wang Q; Liu J; Li P; Meng X; Liu K; Chen W; Liu X; Liu Z
Brain Behav Immun; 2021 Jul; 95():330-343. PubMed ID: 33839232
[TBL] [Abstract][Full Text] [Related]
20. Time to test antibacterial therapy in Alzheimer's disease.
Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP
Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
